Antidepressant shows promise for treating glioblastoma brain tumors
A large-scale drug screening identified the antidepressant vortioxetine as a potential treatment for glioblastoma brain tumors. …
A large-scale drug screening identified the antidepressant vortioxetine as a potential treatment for glioblastoma brain tumors. …
Findings from the international FORT-2 clinical trial indicate that a promising combination treatment that includes immunotherapy is safe and well-tolerated in patients with locally advanced or metastatic bladder cancer. …
Scientists have pinpointed thousands of genetic changes in a gene that may increase the risk of developing breast and ovarian cancers, paving the way for better risk assessment and more personalized care. …
A new study demonstrates that one particular lipid type is critical for cancer immune evasion—so much so that certain cancer cells cannot proliferate without it. …
A large clinical trial has shown that an immunotherapy drug may nearly double the time that high-risk, muscle-invasive bladder cancer patients remain cancer-free after bladder removal surgery. …
A large-scale study analyzing long-term melanoma data reveals important insights into melanoma incidence trends in men and women. …
New preclinical model suggests blocking inflammation pathways may reverse cancer-promoting effects of aging, inspiring early-phase clinical drug trials. …
Researchers have shown in mice a new approach to fighting pancreatic cancer that utilizes a novel nanoparticle drug-delivery system to activate an immune pathway alongside tumor-targeting agents. …
New AI-based digital pathology platform enables extremely fast and accurate analysis of tissue sections from lung cancer patients. …
Next-generation extracellular vesicles containing RNA “dark matter” may lead to less invasive option of liquid biopsy for cancer diagnosis. …
End of content
End of content